Thorne Research to Partner in Personalized Medicine Platform. Health Elements LLC to Acquire WellnessFX, Inc., Creating Comprehensive Platform for Personalized Health Products, Services and InformationWellnessFX affiliation with Thorne Research combines advanced diagnostic technology and resources to help medical professionals use personalized health information to improve patient outcomes.SAN FRANCISCO (December 9, 2013)
– Health Elements, LLC, a leader in medically supervised weight loss, today announced the acquisition of WellnessFX, Inc., the leader in technology and services that clinicians and consumers can use to digitally collect, explain, and track personal health data. The acquisition will combine Health Elements and WellnessFX under the WellnessFX brand. Terms of the deal were not disclosed.
The combined entity will offer health providers and individual patients a range of personalized health services and products, including capabilities in blood testing and other diagnostic tools that can be used to develop more effective health and wellness strategies. In addition, WellnessFX will include access to the full portfolio of products and health information and services available from Thorne Research, a leading provider of nutritional supplements and wellness services available through medical professionals.
"The combination of the Health Elements technology platform with WellnessFX's established brand strengths in personalized health and readily accessible diagnostic services represents a major new advantage for both health professionals and patients," said Paul Jacobson, CEO of Thorne Research and WellnessFX, adding, "By bringing these resources together, WellnessFX will make FDA-approved diagnostic, genetic and treatment information more accessible and usable than ever before to improve the health of thousands of people each year."
Founded in 2010, WellnessFX provides consumer-based online personalized health software, blood tests through leading laboratories and consultations with health professionals. Through this acquisition, WellnessFX diagnostic tools along with Health Elements nutrition tracking tools and other mobile applications will be available to consumers through the 13,000 health practitioners affiliated with Thorne Research. WellnessFX will continue to maintain operations in San Francisco and Los Angeles. In addition to Thorne Research, the largest shareholder in the newly combined entity, other investors include the Helsinn Group, Indena and HEU Holdings, Inc.
Jim Kean, founder and former CEO of WellnessFX, said, "This collaboration is a milestone event in personalized health, bringing together the industry's most advanced diagnostic technologies and resources to create an unparalleled opportunity for healthcare professionals to work more effectively with patients. Never before has this seamless range of diagnostic health services and support been available from one location. WellnessFX will make it easier for clinicians and patients to identify the most effective strategies to support weight loss, management of chronic illnesses, and many other health and wellness goals."About WellnessFX
Headquartered in San Francisco, WellnessFX, Inc., is dedicated to putting health in the hands of the consumer. At the forefront of the consumer health revolution, the leading cloud-based health and wellness destination offers an accessible, streamlined way to collect, interpret, and track personal health data. WellnessFX aggregates personal biomarkers and provides access to licensed practitioners and laboratories. Through partnerships and technology integrations with large blood diagnostics and genetics labs, data is seamlessly organized and communicated through rich, personalized visualizations and delivered via a sleek interface to bring healthcare delivery into the 21st century. Investors include Floodgate, Javelin Venture Partners and Voyager Capital. For more information, please visit www.wellnessfx.com.About Health Elements
Health Elements offers cutting-edge, proprietary health management systems for patients and healthcare professionals targeting medically supervised weight loss. The service includes an easy-to-use patient portal that provides instructions and practical daily actions to guide people toward improving their quality of health and life. With Health Elements, healthcare professionals have unlimited access to clinical data and other research as well as decision-making and patient management tools to support efficient and effective care delivery and to plan and execute patient-specific wellness and prevention strategies. Investors include Thorne Research, the Helsinn Group, Indena and HEU Holdings, Inc.About Thorne Research
Since 1984, Thorne Research has set the standard for exceptional quality manufacturing and formulation of premium hypoallergenic dietary supplements available through licensed healthcare practitioners. With more than 400 products, healthcare practitioners recognize Thorne Research as a global leader in providing dietary supplements of the highest quality and purity. With locations in Sandpoint, ID, and New York City, Thorne Research operates a state-of-the-art manufacturing facility and employs more than 220 people. Further information on Thorne Research is available at www.thorne.com.About H2 Wellness
Founded in 2005, H2 Wellness (H2) has grown to become one of the leading global digital health solutions companies. H2 delivers technology that is focused on behavior modifications through personalized and interactive health portals (web and mobile). Clients from different verticals in the health sector seek such solutions to immediately improve their populations' engagement, health, and ultimately sales through custom health and lifestyle management systems. Accessed through a web browser or mobile device, H2's cloud-based system delivers a highly personalized yet scalable approach to improving customer engagement, communication, social networking and program compliance. H2 serves the medical, pharmaceutical, fitness, nutrition, and weight loss markets – and supports more than two million end users in 14 countries. H2 is a Los Angeles-based company with 67 employees. www.h2wellness.com.
Berry & Company Public Relations
Ph. +1 212-253-8881
firstname.lastname@example.orgTHORNE RESEARCH, DR. MARK HOUSTON, AND THE HYPERTENSION INSTITUTE LAUNCH TRUCARDIAŽ – A NEW VENTURE TARGETING CARDIOVASCULAR HEALTHTruCardiaŽ to offer nutritional supplements and resources to support patient cardiovascular health and better manage cardiovascular risk factorsSANDPOINT, IDAHO, December 5, 2013
– Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements marketed through licensed health-care practitioners, today announced that the company has partnered with Mark Houston, MD, MS, M.Sc, and the Hypertension Institute to launch TruCardiaŽ, a new venture providing novel nutritional supplements and educational programs to support and promote cardiovascular health. Dr. Houston will lead TruCardia's efforts to develop a range of nutritional supplements and patient resources. Dr. Houston is the Director of the Hypertension Institute, one of the nation's leading centers for cardiovascular health and a Cardiovascular Center of Excellence of the Consortium for Southeastern Hypertension Control, treating more than 20,000 patients each year.
The first product available from TruCardiaŽ is LipoCardia™, a nutritional supplement to help maintain healthy lipid levels. Three additional products will be launched in the first half of 2014: CardioPressin™, a nutritional supplement to support normal blood pressure levels, ArterioCare™, a nutritional supplement to support coronary artery blood flow and endothelial function to help maintain cardiovascular health, and MitoBio™, a nutritional supplement to help promote a healthier dynamic heart, enhance cardiac myocyte function, and promote mitochondrial biogenesis and function.
"Over 15 years of clinical research, experience, and clinical application have gone into the development of the TruCardiaŽ suite of nutritional supplements. Thorne Research, known for exceptional quality and purity, is a great partner in this endeavor," said Dr. Houston.
The TruCardiaŽ nutritional supplement product line was developed using the most advanced research technologies available for the support of cardiovascular health. A combination of peer-reviewed medical and scientific literature, metabolomics-based composition and molecular pathway analysis, clinical research, and expert insight was used to determine the range of ingredients and dosing levels to achieve optimal efficacy of the TruCardiaŽ nutritional supplement line.
"Cardiovascular disease is the single leading cause of death globally. By educating patients about the prudent use of nutritional supplements, nutrition, effective tools to monitor their cardiovascular health, and choosing healthier lifestyle options, we can help them better manage their risk of cardiovascular disease. There is significant medical evidence indicating that nutritional supplements can positively impact cardiovascular health. TruCardiaŽ will offer the finest educational and nutritional resources to make a difference in the lives of people who have cardiovascular disease or who may be at risk," said Dr. Houston.
In addition to offering high-quality nutritional supplements, TruCardiaŽ will also support efforts in cardiovascular research and provide specialized physician and patient education programs in cardiovascular health and prevention and the treatment of cardiovascular disease.
"Thorne Research is proud to offer high-quality, evidence-based nutritional supplements to health-care providers to help them support the cardiovascular health of their patients. We are pleased to be working with Dr. Houston to develop new resources that will help patients take an active role in maintaining their cardiovascular health. TruCardiaŽ is another important milestone for Thorne Research as we continue to expand our product portfolio and support the efforts of health-care providers to provide their patients with outstanding products backed by innovative programs in patient and clinician education," said Paul Jacobson, CEO, Thorne Research.About Thorne Research, Inc.
Since 1984, Thorne Research, with more than 300 nutritional supplement products, has set the standard for exceptional quality manufacturing and formulation of advanced technology, pure, highly absorbable nutritional supplements. Thorne Research is recognized by health-care practitioners as a global leader and provider of nutritional supplements and education to licensed health-care practitioners. With locations in Sandpoint, Idaho, and New York City, Thorne Research operates a state-of-the-art manufacturing facility and employs more than 200 people. Further information on Thorne Research is available at www.thorne.com.About Dr. Mark Houston
Dr. Houston is an Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine and the Medical Director of the Division of Human Nutrition at Saint Thomas Hospital, in Nashville, Tennessee. He is triple board-certified in hypertension by the American Society of Hypertension (ASH, FASH), internal medicine (ABIM, FACP), and anti-aging and regenerative medicine (ABAARM, FAARM). He also has dual Masters of Science in Human Nutrition and Masters of Science in Medical Science of Metabolic and Nutritional Medicine. Dr. Houston is a Fellow of the American Heart Association (FAHA) and a Fellow of the American College of Nutrition (FACN). He specializes in the prevention and treatment of hypertension, dyslipidemia, and cardiovascular disease, and has a clinical and research practice in integrative cardiovascular medicine, preventive cardiology, vascular medicine, vascular biology, coronary heart disease, and congestive heart failure. He has pioneered multiple research efforts that demonstrate the effectiveness of nutritional supplements, optimal nutrition, exercise, weight management, and other lifestyle modifications to better manage cardiovascular conditions. Dr. Houston has published over 200 medical articles in peer-reviewed journals, serves on the editorial board for numerous cardiovascular journals, has completed over 120 clinical research studies in cardiovascular disease, and presented over 10,000 lectures worldwide. He has authored several best-selling books including: "What Your Doctor May Not Tell You About Hypertension," "What Your Doctor May Not Tell You About Heart Disease,"
and "The Handbook of Hypertension."
He has been selected by both USA Today
and the Consumers Research Council as one of the Top and Most Influential Physicians in Hypertension and Dyslipidemia in the United States.About the Hypertension Institute
The Hypertension Institute of Nashville, Tennessee, specializes in the prevention, diagnosis, and management of hypertension (high blood pressure), cardiovascular disease, dyslipidemia, vascular aging, and their complications. It provides patients with the latest clinical research, patient care, education, sophisticated cardiovascular specialty primary care, and hypertensive, dyslipidemia, and heart disease treatments. The Hypertension Institute strives to prevent complications such as coronary heart disease, angina, myocardial infarction (heart attack), congestive heart failure, kidney disease, and cerebrovascular accidents (stroke). It is through in-depth consultation, examination, and non-drug and drug treatment that patients are able to permanently modify their lifestyles and reduce cardiovascular risk. The Hypertension Institute offers specialized programs in nutrition; nutritional supplements; exercise, stress management, and weight loss; diagnostic labs; and advanced cardiovascular testing, as well as a Facial Rejuvenation Center (FRC).
Berry & Company Public Relations
Ph. +1 212-253-8881
email@example.comJuly 7, 2013 – Thorne Research Makes Major Gift to Foundations of Naturopathic Medicine ProjectPartnership will include collaboration to support quality of life during healing for oncology patients. (read more)April 30, 2013 – Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in ChinaCollaboration positions wide range of natural health products manufactured by Thorne Research for sale in rapidly expanding Chinese market. (read more)
February 22, 2013 – Thorne Research and HerbalScience Group Announce Discovery and Development Deal for Line of Natural Health ProductsCollaboration expands Thorne Research focus on discovering, developing, producing and commercializing high quality natural health products for global markets. (read more)September 18, 2012 – Thorne Research Launches Thorne Performance, a New Venture in Sports NutritionIn collaboration with Integrative Health Resources, Thorne Research will develop and commercialize a dietary supplement product line and nutritional tools to support a healthy athletic lifestyle. (read more)July 31, 2012 – Thorne Research, Inc., and Helsinn Healthcare SA Announce Oncoqol™ – A Joint Effort to Provide Nutritional Supplements and Personal Care Products to Patients Undergoing Cancer Treatment OncoQOL nutritional supplements and personal care products are now available through oncologists and other medical professionals in the United States and Canada to help patients address nutritional issues and side effects associated with treatment for different types of cancer. (read more)July 25, 2012 – Thorne Research, Integrative Health Resources and Dr. Daniel G. Amen Launch New Venture Targeting Cognitive Health Venture to develop portfolio of supplements, nutritional tools and exercises to support healthy brain function.(read more)October 4, 2011 – Thorne Research and Indena Enter into Strategic Cooperation
Two leading companies in nutritional supplements and botanicals to restore and improve health join together to develop and commercialize innovative and scientifically validated botanical dietary supplements.(read more)August 12, 2011 – Thorne Research Acquires Exclusive Global Rights To Advanced Formulation Of Coenzyme Q10All-natural softgel formulation QCell™ shown to be more absorbent and bioavailable compared to other coenzyme Q10 supplements.(read more)May 11, 2011 – Helsinn Group Invests in Thorne Research and Will Jointly Pursue the Development of Nutritional Products, Information and Support Services in Cancer CareHelsinn Group makes an equity investment for a minority interest in Thorne Research, Inc. and plans to jointly commercialize nutritional supplement products with initial focus on meeting the needs of people living with cancer. (read more)April 15, 2011 – Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative MedicineHealth Elements established as the first service to offer a comprehensive web-based solution to support medical practices and their patients with integrative medical information and education, patient adherence and wellness programs, health and lifestyle recommendations, dietary supplement sourcing, and innovative product development. (read more)February 16, 2011 – Thorne Research is Proud to Announce the Launch of Thorne Vet!Thorne Research is proud to announce the launch of Thorne Vet, dedicated to serving the needs of the companion pet and equine markets. (read more)June 24, 2010 – Thorne Research Announces Combination with Diversified Natural ProductsThorne Research, Inc. announced that it has merged with Diversified Natural Products (DNP). The combination of the two companies joins the clinically researched product portfolio of DNP with the hypo-allergenic, exceptionally formulated product line of Thorne. (read more)